Voriconazole therapeutic drug monitoring: focus on safety
- PMID: 20021293
- DOI: 10.1517/14740330903485637
Voriconazole therapeutic drug monitoring: focus on safety
Abstract
Importance of the field: Voriconazole has been widely used for the treatment of invasive fungal diseases, particularly invasive aspergillosis. Drug-drug interactions are, however, the main drawback associated with voriconazole use, since this drug suffers from extensive hepatic metabolism.
Areas covered in this review: This article reviews the current literature on voriconazole therapeutic drug monitoring, with a special focus on drug safety.
What the reader will gain: An update on voriconazole metabolism, drug interactions, toxicity and the relation of these with voriconazole drug concentrations.
Take home message: Therapy with voriconazole may be better guided by measuring voriconazole concentrations in the plasma.
Similar articles
-
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.Ther Drug Monit. 2011 Feb;33(1):86-93. doi: 10.1097/FTD.0b013e31820530cd. Ther Drug Monit. 2011. PMID: 21192313
-
Pharmacogenomics of the triazole antifungal agent voriconazole.Pharmacogenomics. 2011 Jun;12(6):861-72. doi: 10.2217/pgs.11.18. Pharmacogenomics. 2011. PMID: 21692616 Review.
-
Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype.Antimicrob Agents Chemother. 2006 Sep;50(9):3227-8. doi: 10.1128/AAC.00551-06. Antimicrob Agents Chemother. 2006. PMID: 16940139 Free PMC article. No abstract available.
-
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.Mycoses. 2011 Nov;54(6):e877-9. doi: 10.1111/j.1439-0507.2011.02016.x. Epub 2011 May 25. Mycoses. 2011. PMID: 21615537 Free PMC article.
-
Pharmacology and clinical use of voriconazole.Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):83-94. doi: 10.1517/17425250903463878. Expert Opin Drug Metab Toxicol. 2010. PMID: 19947892 Review.
Cited by
-
Voriconazole-Induced Cholestatic Hepatotoxicity in an Immune Competent Patient.Cureus. 2022 Jan 17;14(1):e21346. doi: 10.7759/cureus.21346. eCollection 2022 Jan. Cureus. 2022. PMID: 35103217 Free PMC article.
-
Pre-Existing Liver Disease and Toxicity of Antifungals.J Fungi (Basel). 2018 Dec 10;4(4):133. doi: 10.3390/jof4040133. J Fungi (Basel). 2018. PMID: 30544724 Free PMC article. Review.
-
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.Antimicrob Agents Chemother. 2016 Apr 22;60(5):2727-31. doi: 10.1128/AAC.02830-15. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26883707 Free PMC article.
-
Voriconazole-Induced Hepatotoxicity Presenting With Severe Hepatic Encephalopathy After Liver Transplantation.ACG Case Rep J. 2019 Feb 25;6(3):1-4. doi: 10.14309/crj.0000000000000010. eCollection 2019 Mar. ACG Case Rep J. 2019. PMID: 31620506 Free PMC article.
-
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.Medicine (Baltimore). 2017 Oct;96(42):e8039. doi: 10.1097/MD.0000000000008039. Medicine (Baltimore). 2017. PMID: 29049191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials